Skip to main content

Table 2 Subgroup analysis of the associations between change in fasting glucose and the risk of myocardial infarction

From: The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study

Fasting glucose level at baseline (mg/dL)

NFG (< 100.0 mg/dL)

IFG (100.0–125.9 mg/dL)

Fasting glucose level after 2-year (mg/dL)

NFG (< 100.0 mg/dL)

IFG (100.0–125.9 mg/dL)

DFG (≥ 126.0 mg/dL)

NFG (< 100.0 mg/dL)

IFG (100.0–125.9 mg/dL)

DFG (≥ 126.0 mg/dL)

Age < 65 years

 Subtotal (N)

136,764

32,057

3188

28,272

19,977

3615

 Number of cases (n)

482

151

15

124

92

31

 HR (95% CI)

1

1.06 (0.88–1.28)

0.85 (0.51–1.42)

1.15 (0.88–1.51)

1

1.49 (0.98–2.25)

Age ≥ 65 years

 Subtotal (N)

19,957

5765

829

5335

3879

849

 Number of cases (n)

199

74

12

65

51

22

 HR (95% CI)

1

1.23 (0.94–1.61)

1.26 (0.69–2.32)

0.93 (0.64–1.34)

1

2.02 (1.21–3.35)

Men

 Subtotal (N)

83,348

23,763

2790

20,418

16,354

3240

 Number of cases (n)

539

183

20

147

120

43

 HR (95% CI)

1

1.10 (0.93–1.31)

0.92 (0.58–1.43)

1.04 (0.81–1.32)

1

1.57 (1.10–2.23)

Women

 Subtotal (N)

73,373

14,059

1227

13,189

7502

1224

 Number of cases (n)

142

42

7

42

23

10

 HR (95% CI)

1

1.11 (0.78–1.57)

1.25 (0.55–2.85)

1.16 (0.69–1.95)

1

2.11 (0.99–4.47)

BMI < 25.0 kg/m2

 Subtotal (N)

111,438

24,195

2411

22,436

14,195

2368

 Number of cases (n)

439

138

15

112

81

27

 HR (95% CI)

1

1.14 (0.94–1.38)

0.91 (0.54–1.56)

0.98 (0.74–1.31)

1

1.71 (1.10–2.65)

BMI ≥ 25.0 kg/m2

 Subtotal (N)

45,255

13,615

1605

11,157

9651

2095

 Number of cases (n)

242

87

12

77

62

26

 HR (95% CI)

1

1.05 (0.82–1.35)

1.10 (0.62–1.98)

1.19 (0.85–1.67)

1

1.63 (1.02–2.60)

  1. Hazard ratio analyzed by Cox proportional hazards regression analysis adjusted for age, sex, socioeconomic status, physical activity, smoking status, alcohol consumption, body mass index, blood pressure, total cholesterol, Charlson comorbidity index, and baseline fasting glucose level
  2. n number, HR hazard ratio, CI confidential interval, NFG normal fasting glucose (< 100.0 mg/dL), IFG impaired fasting glucose (100.0–125.9 mg/dL), DFG diabetic fasting glucose (≥ 126.0 mg/dL)